口服甲基納曲酮的生物利用度隨基於磷脂酰胆碱的製劑提高

• 收藏
• 分享

专利权人:

THE UNIVERSITY OF CHICAGO

发明人:

YUAN, CHUN-SU,WANG, CHONG-ZHI,GU, MAOJIAN,LIN, DONG-HAI

申请号：

HK15108676.7

公开号：

HK1207940A

申请日:

2015.09.07

申请国别(地区):

HK

年份:

2016

代理人:

摘要：

A pharmaceutical composition comprising a phosphatidylcholine-based opioid receptor antagonist formulation, as well as methods of their use and methods of their preparation are provided herein. Such pharmaceutical composition may be used for treating and preventing opioid-induced side effects in patients, and may be provided to chronic opioid users as well.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/